Replies to post #4273 on Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

We’re talking about a 2-3% increase in the basic share count and less than a 5% increase in the diluted count after adjusting for the higher average share price during 2Q11 (which brings more options into the money). In other words, not a major factor.